Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas

Citation
Wa. Faubion et al., Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas, J CLIN INV, 103(1), 1999, pp. 137-145
Citations number
42
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF CLINICAL INVESTIGATION
ISSN journal
00219738 → ACNP
Volume
103
Issue
1
Year of publication
1999
Pages
137 - 145
Database
ISI
SICI code
0021-9738(199901)103:1<137:TBSIRH>2.0.ZU;2-6
Abstract
Cholestatic liver injury appears to result from the induction of hepatocyte apoptosis by toxic bile salts such as glycochenodeoxycholate (GCDC). Previ ous studies from this laboratory indicate that cathepsin B is a downstream effector protease during the hepatocyte apoptotic process. Because caspases can initiate apoptosis, the present studies were undertaken to determine t he role of caspases in cathepsin B activation. Immunoblotting of GCDC-treat ed McNtcp.24 hepatoma cells demonstrated cleavage of poly(ADP-ribose) polym erase and Iamin B-1 to fragments that indicate activation of effector caspa ses. Transfection with CrmA, an inhibitor of caspase 8, prevented GCDC-indu ced cathepsin B activation and apoptosis. Consistent with these results, an increase in caspase 8-like activity was observed in GCDC-treated cells. Ex amination of the mechanism of GCDC-induced caspase 8 activation revealed th at dominant-negative FADD inhibited apoptosis and that hepatocytes isolated from Fas-deficient lymphoproliferative mice were resistant to GCDC-induced apoptosis. After GCDC treatment, immunoprecipitation experiments demonstra ted Fas oligomerization, and confocal microscopy demonstrated Delta FADD-GF P (Fas-associated death domain-green fluorescent protein, aggregation in th e absence of detectable Fas Ligand mRNA. Collectively, these data suggest t hat GCDC-induced hepatocyte apoptosis involves ligand-independent oligomeri zation of Fas, recruitment of FADD, activation of caspase 8, and subsequent activation of effector proteases, including downstream caspases and cathep sin B.